GLP-1
Last updated: January 23, 2026
For informational purposes only. Not medical advice. Always consult a healthcare professional.
Tried GLP-1? Be part of the collective knowledge. Share your experience - your insights help others on their journey.
What Is GLP-1?
Glucagon-like peptide-1 (GLP-1) is an incretin hormone derived from the intestine that stimulates insulin secretion in a glucose-dependent manner while suppressing glucagon release. It acts on the brain to increase satiety, delays gastric emptying, and is primarily used to treat type 2 diabetes and obesity through GLP-1 receptor agonists.
This is a peptide. Most peptides are research chemicals requiring reconstitution and subcutaneous injection. Purity and storage conditions matter.
GLP-1 Research & Studies
01 GLP-1-based therapies for diabetes, obesity and beyond ▸
This review confirms GLP-1 therapies like semaglutide and tirzepatide are highly effective for glucose control and weight loss while reducing cardiovascular and renal mortality.
View Study (PubMed)02 Hypoglycemic effect of C. butyricum-pMTL007-GLP-1 engineered probiotics on type 2 diabetes mellitus ▸
Engineered probiotics designed to continuously deliver GLP-1 successfully lowered blood glucose, improved islet cell function, and restored gut microbiota in diabetic models.
View Study (PubMed)03 GDF8 and activin A blockade protects against GLP-1-induced muscle loss while enhancing fat loss ▸
GLP-1 receptor agonists can cause significant muscle loss as a side effect, but blocking myostatin and activin A can preserve muscle mass and optimize metabolic outcomes.
View Study (PubMed)04 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease ▸
Clinical guidelines now formally recommend GLP-1 receptor agonists for patients with chronic coronary disease and type 2 diabetes to reduce major adverse cardiovascular events.
View Study (PubMed)05 The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective ▸
GLP-1 RAs show potential in managing reproductive health disorders like PCOS by restoring menstrual frequency and improving metabolic health.
View Study (PubMed)06 GLP-1 rescued gestational diabetes mellitus-induced suppression of fetal thalamus development ▸
Animal models suggest GLP-1 may protect fetal neurological development, specifically correcting impaired thalamocortical axon growth caused by maternal diabetes.
View Study (PubMed)GLP-1 User Reviews & Experiences
Sentiment score computed from aggregated public user reports, forums, and community discussions. Not a clinical measure.
Users report transformative weight loss and high effectiveness for glycemic control, though they frequently discuss managing gastrointestinal side effects and the risk of muscle mass reduction.
GLP-1 Benefits, Dosage & Side Effects
- Appetite Suppression: Users experience a significant reduction in 'food noise' and increased feelings of fullness.
- Glycemic Control: Proven to lower HbA1c and maintain stable blood sugar levels by inducing insulin secretion.
- Cardiovascular Protection: Clinical data indicates a reduction in major adverse cardiovascular events (MACE) in high-risk patients.
- Muscle Atrophy: Research and users note a potential loss of lean tissue alongside fat loss during rapid weight reduction.
- Rapid Weight Loss: Highly effective for obesity management, particularly when combined with lifestyle interventions.
- Chronic Management: Shows high long-term success for reversing prediabetes and managing type 2 diabetes.
- Metabolic Health: Effectively improves dyslipidemia and markers of inflammation like IL-6 and TNF-alpha.
- PCOS Regulation: Emerging utility in restoring menstrual cycles and managing insulin resistance in adolescents with PCOS.
- Titration Schedule: Commonly started at a low 'induction' dose (e.g., 0.25mg) to minimize nausea, increasing every 4 weeks.
- Short-acting vs Long-acting: Short-acting analogs may be used to specifically target postprandial glucose, while long-acting versions (weekly) are preferred for weight loss.
- Engineered Probiotics: Novel delivery methods via C. butyricum or L. gasseri are being researched to bypass daily injections.
- Nutraceutical Induction: 200mg daily of Eriocitrin has been shown to naturally increase endogenous GLP-1 levels by 17%.
- Gastrointestinal Distress: Nausea, vomiting, and constipation are the most frequently reported user side effects.
- Muscle Loss: Loss of muscle mass is a significant concern, often requiring high protein intake and resistance training to mitigate.
- Islet Cell Apoptosis: In diseased states, GLP-1 therapies help retard islet cell apoptosis, which is a positive secondary effect.
- Gallbladder Issues: Rapid weight loss associated with GLP-1 can increase the risk of gallbladder-related complications.
- Prescription Requirement: GLP-1 receptor agonists (Semaglutide, Tirzepatide) are strictly prescription-only medications.
- Supply Shortages: Significant global demand has led to frequent sourcing challenges and intermittent availability for patients.
Related Compounds
Community Reviews
Share your experience with GLP-1 and help others make informed decisions.
Write a Review
Sign in to leave a review